Correlation Between KABE Group and Annexin Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both KABE Group and Annexin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KABE Group and Annexin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between KABE Group AB and Annexin Pharmaceuticals AB, you can compare the effects of market volatilities on KABE Group and Annexin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KABE Group with a short position of Annexin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of KABE Group and Annexin Pharmaceuticals.

Diversification Opportunities for KABE Group and Annexin Pharmaceuticals

0.66

Correlation Coefficient

KABE Group  Annexin Pharmaceuticals

Poor diversification

The 3 months correlation between KABE and Annexin is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding KABE Group AB and Annexin Pharmaceuticals AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annexin Pharmaceuticals and KABE Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KABE Group AB are associated (or correlated) with Annexin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annexin Pharmaceuticals has no effect on the direction of KABE Group i.e., KABE Group and Annexin Pharmaceuticals go up and down completely randomly.

Pair Corralation between KABE Group and Annexin Pharmaceuticals

Assuming the 90 days trading horizon KABE Group AB is expected to generate 0.25 times more return on investment than Annexin Pharmaceuticals. However, KABE Group AB is 4.06 times less risky than Annexin Pharmaceuticals. It trades about -0.16 of its potential returns per unit of risk. Annexin Pharmaceuticals AB is currently generating about -0.04 per unit of risk. If you would invest  30,300  in KABE Group AB on December 31, 2024 and sell it today you would lose (3,800) from holding KABE Group AB or give up 12.54% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

KABE Group AB  vs.  Annexin Pharmaceuticals AB

KABE Group AB

Risk-Adjusted Performance

Very Weak

Over the last 90 days KABE Group AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental drivers remain somewhat strong which may send shares a bit higher in May 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Annexin Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Annexin Pharmaceuticals AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in May 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with KABE Group and Annexin Pharmaceuticals

The main advantage of trading using opposite KABE Group and Annexin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KABE Group position performs unexpectedly, Annexin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annexin Pharmaceuticals will offset losses from the drop in Annexin Pharmaceuticals' long position.

The idea behind KABE Group AB and Annexin Pharmaceuticals AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.